Research and experimental development on natural sciences and engineering
AGIANA PHARMACEUTICALS AS
Revenue 2024
NOK 535,000
Operating profit
NOK −4.7m
Equity
NOK 13.4m
Incorporated
2021
Share capital
NOK 37,000
Roles
Daglig lederRizwan Iqbal Hussain
Regnskapsfører
Styrets lederThomas Ramdahl
StyremedlemMargareta Elisabeth Björk
StyremedlemAnders Pablo Kapstad
StyremedlemJames Daniel Dezazzo
StyremedlemTimothy James Sullivan
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| DART NEURO SCIENCE LLC | 49.1% | 17686.000000 | 2025 |
| INVEN2 AS | 37.1% | 13364.000000 | 2025 |
| JONAS SKOGESTAD | 8.3% | 3000.000000 | 2025 |
| JAN MAGNUS ARONSEN | 5.5% | 2000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.